Varian Medical Systems (VAR) Reports In-Line Q2 EPS, Revenues Beat; Withdraws FY20 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Varian Reports Results for Second Quarter of Fiscal Year 2020; Withdraws 2020 Guidance
May 4, 2020 4:15 PM EDTPALO ALTO, Calif., May 4, 2020 /PRNewswire/ --Â
Second Quarter 2020 Summary
Oncology Systems gross orders grew 1% in dollars or 2% in constant currency in the quarter; trailing twelve months gross orders grew 5% in dollars or 6% in constant currency 15 EthosTM orders received, including 11 in North America, 3 in Europe and 1 in Asia-Pacific Two Proton orders awarded in Asia-Pacific Total company revenues grew 2% in dollars, or 3% in constant currency, to $794 million; organic revenues declined 1%(1) GAAP operating earnings declined 50% at 6.9% of revenues; non-GAAP operating earnings declined 14% at 12.9% of revenues GAAP net... More